Spichemis Pharmaceuticals Private Limited
About Spichemis Pharmaceuticals Private Limited
Data last updated:
Spichemis Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 28 January 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2016PTC102936.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Mohd Khaleel and Azmath Aijaz.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No. 8 – 4 – 544/N/5 Sultan Nagar Erragadda, Hyderabad, Telangana, India – 500018.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.51 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹62,856 (net margin -41.6%) and EBITDA of -₹62,856 (EBITDA margin -41.6%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Spichemis Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressH No. 8 – 4 – 544/N/5 Sultan Nagar Erragadda, Hyderabad, Telangana, India – 500018
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Spichemis Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Spichemis Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Spichemis Pharmaceuticals Private Limited, buy the company report.
Financials of Spichemis Pharmaceuticals Private Limited
FY 2025 filings availableSpichemis Pharmaceuticals Private Limited reported revenue of ₹1.51 Lakh (up 244% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 244% in the latest year. EBITDA rose 30% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹62,856 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹62,856 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -41.6% | ||||
| Net Profit Margin | -41.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Spichemis Pharmaceuticals Private Limited, buy the company report.
Board of directors of Spichemis Pharmaceuticals Private Limited
Spichemis Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohd Khaleel | Director | 28 Jan 2016 | 10 Years 9 Months | Current |
| Azmath Aijaz | Director | 28 Jan 2016 | 10 Years 9 Months | Current |
Auditor
Spichemis Pharmaceuticals Private Limited is audited by K VENKATESWARA RAO & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K VENKATESWARA RAO & ASSOCIATES | FY 2020 | 006374S |
Shareholding
The shareholding of Spichemis Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Spichemis Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Spichemis Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spichemis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Spichemis Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Spichemis Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Azmath Aijaz was appointed as Director on 28 Jan 2016.
Frequently asked questions
Spichemis Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 28 January 2016 (10+ years old) and is registered under CIN U24100TG2016PTC102936.
Spichemis Pharmaceuticals has 2 current directors:
- Mohd Khaleel - Director
- Azmath Aijaz - Director
The latest financial statements of Spichemis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The CIN (Corporate Identification Number) of Spichemis Pharmaceuticals is U24100TG2016PTC102936. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spichemis Pharmaceuticals was incorporated on 28 January 2016, making it 10+ years old. It is registered with the Registrar of Companies, Hyderabad.
Azmath Aijaz was appointed as Director on 28 Jan 2016. Mohd Khaleel was appointed as Director on 28 Jan 2016.
The registered office of Spichemis Pharmaceuticals is at H No. 8 – 4 – 544N5 Sultan Nagar Erragadda, Hyderabad, Telangana, India – 500018.
Spichemis Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Spichemis Pharmaceuticals is compliant as of 27 July 2026. The company is actively filing with the Registrar of Companies.
Spichemis Pharmaceuticals can be reached at its registered office: H No. 8 – 4 – 544N5 Sultan Nagar Erragadda, Hyderabad, Telangana, India – 500018.